Other Clinical Liver Research Studies
Investigators
Arrowhead
Enrolling: No
Principle Investigator: Raj Vuppalanchi, MD
Duration: Upwards of 2 years
Patient Population: F2 - 3
Drug(s): ARO-AAT
Interested in this study? Please contact the following coordinator:
Holly King
hrking1@iu.edu
(317) 278-6200
Fibroscan Database
Enrolling: Yes
Principle Investigator: Naga Chalasani, MD
Duration: 1 visit
Interested in this study? Please contact the following coordinator:
Anusha Vallapuri
avallapu@iu.edu
(317) 278-6216
Hepatic Adenoma Biorepository
Enrolling: Yes
Principle Investigator: Craig Lammert, MD
Duration: 1 visit
Patient Population: Hepatic adenoma with history of oral contraceptive use.
Interested in this study? Please contact the following coordinator:
Kelsey Green
greenke@iu.edu
(317) 278-9292
Liver Biopsy Collection
Enrolling: Yes
Principle Investigator: Naga Chalasani, MD
Duration: 1 visit
Patient Population: Patients receiving liver biopsies excluding those with viral hepatitis and alcoholic liver disease.
Interested in this study? Please contact the following coordinators:
Jake McCarty
jacmccar@iu.edu
(317) 278-6305
Dheeksha Ranginani
(317) 278-6203
Anusha Vallapuri
(317) 278-6216
Lori Dunigan-Jones
(317) 278-6222
Palliative Care Within ESLD
Enrolling: Yes
Principle Investigator: Eric Orman, MD
Duration: 1 year, 7 visits required, but 4 can be completed over the phone.
Patient Population: Adults over 18 years old with new onset or ongoing complications of End Stage Liver Disease (ESLD) including Hepatocellular Cancer (HCC), with a caregiver willing to participate.
Interested in this study? Please contact the following coordinator:
Nicole Garcia
(317) 278-0411
Post Liver Transplant Quality of Life Sub-Study
Enrolling: Yes
Principle Investigator: Naga Chalasani, MD
Duration: 1 visit
Patient Population: Patients that are over 18 years old that have had a liver transplant.
Interested in this study? Please contact the following coordinator:
Janeth Castano
(317) 274-8422
Ultragenyx Wilson’s
Principle Investigator: Craig Lammert, MD
Duration: 3 years
Patient Population: 18 and older, diagnosed with Wilson's disease.
Drug(s): Gene therapy product
Interested in this study? Please contact the following coordinator:
Kelsey Green
(317) 278-9292
Understanding Racial Disparities in Curative Therapies for Hepatocellular Carcinoma: A Prospective Cohort Study
Enrolling: On Hold
Principle Investigator: Naga Chalasani, MD
Duration: 1 visit
Patient Population: Patients that are over 18 years old that have had a liver transplant.
Velacur (Portal Hypertension)
Enrolling: Yes
Principle Investigator: Samer Gawrieh, MD
Duration: 5 years
Patient Population: 21+ chronic liver disease, with upper endoscopy or transjugular liver biopsy with pressure measurements within 6 months of visit
Interested in this study? Please contact the following coordinator:
Emily Smith
(317) 274-1692
Closed Studies
-
TREAT 005
Enrolling: No
Duration: 42 days
Patient Population: Adults 21-65 years old, healthy controls with no alcohol use or heavy alcohol drinkers without liver disease.
-
Cystic Fibrosis Study
Enrolling: No
Principle Investigator: Naga Chalasani, MD
Duration: 1 visit
Patient Population: Aged 18 or greater with a diagnosis of cystic fibrosis.